https://m2.mtmt.hu/ hun 2026-09-21 19:42 JournalArticle 32099838 VALIDATED true 0 false 2025-06-19T00:06:27.195+0000 2022-02-09T07:29:58.863+0000 2021-07-11T07:56:45.083+0000 true 10062250 Molnár-Taga Márta /api/admin/10062250 Admin true 10062250 2025-07-07T13:18:39.007+0000 2025-07-07T13:18:39.007+0000 2021-07-11T08:01:32.324+0000 true 10062250 Molnár-Taga Márta /api/admin/10062250 Admin true 10062250 true false true 24 24 /api/publicationtype/24 PublicationType 1 true 24 JournalArticle true 1134514 Survey paper true 24 24 /api/publicationtype/24 PublicationType 1 true 24 JournalArticle /api/subtype/1134514 Összefoglaló cikk SubType 102 true 1134514 true 1 /api/category/1 Category true 1 FARSANG, CSABA Hypertonia, COPD és Covid-19. Fókuszban az antihipertenzív terápia Hypertension, copd and covid-19. focus on antihypertensive therapy true false /api/journal/1216892 REVIEWED true true 1216892 true 1216892 true 0866-4811 2063-4161 Journal HUNGARIAN 31 5-6 193 199 193 7 2021 Chronic obstructive pulmonary disease is a very common comorbidity of hypertension and it is often unrecognised by physicians. The factors involved in the pathomechanism of both diseases should be realised when choosing treatment. Among factors, hypoxia, increased tone of sympathetic nervous system and activation of reninangiotensin- aldosterone system should primarily be considered. Vascular wall damage and endothelial dysfunction has an important role in both conditions. The goals of treatment are elimination of risk factors, optimizing the blood pressure, the consequential prevention of cardio-cerebrovascular, renal and pulmonary damage; finally prolonging the patients' life and improving their quality of life as well. Both hypertension and COPD significantly worsen the condition of COVID-19 patients since they increase the severity of the disease and the rate of in-patients' and their mortality. In the treatment of hypertension among COPD and COVID-19 patients there must be emphasized the medication inhibiting of renin-angiotensin-aldosterone system, such as angiotensin-converting en - zyme inhibitors or angiotensin-II AT1 re - cep tor antagonists. Special attention concerned the beneficial effect of mineralocorticoid receptor antagonist spironolactone. Other antihypertensive drugs (calcium channel blockers, thiazide-like diu retics, high selectivity β1 receptor antagonists) may supplement the treatment if necessary. Long-acting β2 receptor agonists, muscarinic receptor antagonists and inhalation corticosteroids may be administered in double or triple combination also in hypertension and COPD as well. It is important to note, that statin therapy and also vitamin D3 improve the condition of COVID-19 patients. © 2021 Literatura Medica Publishing House. All rights reserved. true true 2021 false false true false true false CLOSED 2025-06-19 false 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 Q4 false false false false 2021-07-10T08:01:32.241+0000 Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I); LAM szerkesztősége (Kiadók / Önkéntes) 1 10 2 1 0 false Language 10001 /api/language/10001 Magyar Hungarian true 1 true PersonAuthorship 96784765 /api/authorship/96784765 1 1.0 true false true Author 10000365 /api/author/10000365 Farsang Csaba true 10000365 true FARSANG CSABA true false false AuthorshipType 1 /api/authorshiptype/1 0 true 0 true false true Institute 20499 /api/institute/20499 0 false true true LAM szerkesztősége LAM szerkesztősége true 20499 true PublicationIdentifier 19004496 /api/publicationidentifier/19004496 PlainSource 6 /api/publicationsource/6 PublicationSourceType 10001 /api/publicationsourcetype/10001 true true true DOI DOI https://doi.org/@@@ true true 6 true CLOSED IDENTICAL 10.33616/LAM.31.013 https://doi.org/10.33616/LAM.31.013 false true PublicationIdentifier 19004495 /api/publicationidentifier/19004495 PlainSource 3 /api/publicationsource/3 PublicationSourceType 10003 /api/publicationsourcetype/10003 false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 85108558473 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85108558473 false true Keyword 1880 /api/keyword/1880 true 1880 true Keyword 4591 /api/keyword/4591 true 4591 true Keyword 4807 /api/keyword/4807 true 4807 true Keyword 1015312 /api/keyword/1015312 true 1015312 true Keyword 2006271 /api/keyword/2006271 true true SjrRating 11396849 /api/sjrrating/11396849 2397 1.0 journal RatingType 10002 /api/ratingtype/10002 sjr true true ClassificationExternal 2701 /api/classificationexternal/2701 true 2701 true Q4 DIRECT true true /api/publication/32099838 <div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" mtid="10000365"><a href="/gui2/?type=authors&mode=browse&sel=10000365" target="_blank">FARSANG CSABA ✉ (<span class="authorship-author-name">Farsang Csaba</span> <span class="authorAux-mtmt"> Vérnyomásszabályozás, cardiologia, nephrologia,...</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Farmakológiai és Farmakoterápiás Intézet</span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;32099838" target="_blank">Hypertonia, COPD és Covid-19. Fókuszban az antihipertenzív terápia</a></div> <div> <span class="journal-title">LEGE ARTIS MEDICINAE</span> <span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/0866-4811">0866-4811</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/2063-4161">2063-4161</a>)</span>: <span class="journal-volume">31</span> <span class="journal-issue">5-6</span> <span class="page"> pp 193-199 </span> <span class="year">(2021)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Magyar | </span> <span class="identifiers"> <span class="id identifier oa_CLOSED" title=" Zárt "> <a style="color:blue" title="10.33616/LAM.31.013" target="_blank" href="https://doi.org/10.33616/LAM.31.013"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85108558473" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85108558473"> Scopus </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Medicine (miscellaneous)&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q4</div> </div></OnlyViewableByAuthor> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;32099838&sort=publishedYear,desc&sort=title"> Idézett közlemények száma: 1 </a> </div> <div class="mtid"><span class="long-pub-mtid">Közlemény: 32099838</span> | <span class="status-data status-VALIDATED"> Egyeztetett </span> Forrás Idéző | <span class="type-subtype">Folyóiratcikk ( Összefoglaló cikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData">Scopus</span> </div> <div class="special-affiliations"> Speciális affiliáció: LAM szerkesztősége </div> <div class="lastModified">Utolsó módosítás: 2022.02.09. 08:29 Kun Zsanett (Kiadói/szerkesztőségi admin 3) </div> </div></div>